<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03073070</url>
  </required_header>
  <id_info>
    <org_study_id>201612763</org_study_id>
    <nct_id>NCT03073070</nct_id>
  </id_info>
  <brief_title>RBC Lifespan Measurement in Diabetic Children</brief_title>
  <official_title>Red Blood Cell Lifespan Measurement in Diabetic Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Iowa</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Iowa</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      HbA1c, a measure of mean blood glucose over the lifespan of a red blood cell (RBC), is a
      marker of increasing importance both for assessing glycemic control in children with known
      diabetes and for the diagnosis of diabetes in children. HbA1c has demonstrated poor
      reliability in diagnosis and management of pediatric diabetes and the most plausible reason
      for this unreliability is that the reference ranges of HbA1c were established based on
      120-day RBC lifespan observed in adults, without considering the RBC lifespan difference
      between children and adults. The proposed studies will for the first time determine RBC
      lifespan in diabetic children
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">November 15, 2017</start_date>
  <completion_date type="Anticipated">September 2019</completion_date>
  <primary_completion_date type="Anticipated">September 2019</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Measurement of RBC survival in diabetic children using biotin-labeled RBCs</measure>
    <time_frame>50 days to 120 days</time_frame>
    <description>the lifespan of red blood cells in children with diabetes</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">16</enrollment>
  <condition>Diabetes</condition>
  <condition>Red Blood Cell Survival</condition>
  <arm_group>
    <arm_group_label>Biotin labeled RBCs in 4-10 year old diabetes children</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Biotin labeled autologous RBCs will be transfused to the subjects</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Biotin labeled RBCs in 10-18 year old diabetes children</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Biotin labeled autologous red blood cells will be transfused to the subjects</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>biotin labeled RBCs</intervention_name>
    <description>Autologous red blood cells are biotin labeled and transfused to the subjects. Survival of these red blood cells is tracked through examination of blood samples until no biotin-labeled red blood cells is detectable.</description>
    <arm_group_label>Biotin labeled RBCs in 4-10 year old diabetes children</arm_group_label>
    <arm_group_label>Biotin labeled RBCs in 10-18 year old diabetes children</arm_group_label>
    <other_name>biotinylated RBCs</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  children with either type1 or type 2 diabetes between 4-18 years old

        Exclusion Criteria:

          -  consumption of biotin supplements or raw eggs within 30 days;

          -  history of gastrointestinal blood loss;

          -  heart failure ;

          -  active viral or bacterial infection;

          -  hemoglobinopathy;

          -  prior history of liver disease with transaminases more than 3 times the upper limit of
             normal for age;

          -  uncontrolled thyroid disease;

          -  anemia (whole blood HCT&lt;33);

          -  history of renal disease (prior serum creatinine more than &gt;1.5 mg/dlL);

          -  detectable antibody to biotin.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Guohua An, MD, PhD</last_name>
    <phone>319-467-4600</phone>
    <email>guohua-an@uiowa.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Iowa</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guohua An, MD, PhD</last_name>
      <phone>319-467-4600</phone>
      <email>guohua-an@uiowa.edu</email>
    </contact>
    <contact_backup>
      <last_name>Demet Nalbant, PhD</last_name>
      <phone>319-335-8485</phone>
      <email>demet-nalbant@uiowa.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 18, 2016</study_first_submitted>
  <study_first_submitted_qc>March 2, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 8, 2017</study_first_posted>
  <last_update_submitted>October 24, 2017</last_update_submitted>
  <last_update_submitted_qc>October 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Iowa</investigator_affiliation>
    <investigator_full_name>Guohua An</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>diabetic children</keyword>
  <keyword>RBC lifespan</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Biotin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

